Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117779 · ClinicalTrials.gov registry record
Tracking Renal Tumors After Cryoablation Evaluation
A clinical trial, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- 246
- Enrollment target
NCT01117779: Clinical Trial study, sponsored by Boston Scientific Corporation.
NCT01117779 is a clinical trial that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 246 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01117779 was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- 246 participants
- Enrollment target
Study Summary
TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollment into the registry. Subjects will be observed for five years from the date of their cryoablation procedure.
Primary Outcome
Changes to lesion size using greatest trans-axial diameter (cm) from baseline through the follow-up intervals.
Interventions
- DEVICE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2010-07-09 |
| Est. Completion | 2020-11-24 |
Why NCT01117779 stopped before completion
NCT01117779 is an observational study that tracks outcomes without assigning an intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01117779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01117779 about?
NCT01117779 is a clinical study titled "Tracking Renal Tumors After Cryoablation Evaluation". TRACE is an observational, open-label, single-arm, multi-center registry of subjects who have undergone renal lesion cryoablation per their physician's standard of care. Patients 18 years of age or older who have been determined to be an appropriate candidate for cryoablation will be offered enrollm...
What is the current status of trial NCT01117779?
This trial is currently terminated. The enrollment target is 246 participants. The study started on 2010-07-09. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT01117779?
The interventions under investigation include: Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT01117779?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI